Role of NUCB2/nesfatin-1 as a Possible Biomarker

Suleyman Aydin
  • Current Pharmaceutical Design, November 2013, Bentham Science Publishers
  • DOI: 10.2174/138161281939131127143422

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

http://dx.doi.org/10.2174/138161281939131127143422

The following have contributed to this page: Professor Suleyman Aydin

In partnership with: